| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 2 | +236K | 99.9% | $0.62 | +$145K |
| Sells | 1 | -155 | 0.1% | $0.77 | -$119 |
| Net | +1 | +236K | 99.9% | +$145K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | Other*, 10%+ Owner | $6.73M | Mar 31, 2025 | ||
| Vincent J. Angotti | CHIEF EXECUTIVE OFFICER, Director | $278K | +$139K | +100% | Apr 2, 2025 |
| Mark G. Edwards | Director | $190K | Jun 17, 2021 | ||
| Pamela P. Palmer | Chief Medical Officer | $65.1K | Mar 3, 2024 | ||
| Shakil Aslam | Chief Medical Officer | $33.5K | +$6.04K | +22% | Apr 2, 2025 |
| Raffi Asadorian | Chief Financial Officer | $27.7K | -$119 | -0.43% | Apr 2, 2025 |
| Badri N. Dasu | Chief Engineering Officer | $24.6K | Apr 2, 2025 | ||
| Adrian Adams | Director | $15K | Jun 24, 2024 | ||
| Marina Bozilenko | Director | $5.38K | Jun 24, 2024 | ||
| Mark A. Wan | Director | $5.16K | Jun 24, 2024 | ||
| Stephen J. Hoffman | Director | $5.16K | Jun 24, 2024 | ||
| Jill Marie Broadfoot | Director | $4.81K | Jun 24, 2024 | ||
| Howard B. Rosen | Director | $3.85K | Oct 10, 2023 | ||
| Abhinav Jain | Director | $3.42K | Jun 24, 2024 | ||
| Richard Afable | Director | $1.79K | Oct 10, 2023 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|